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Summary
Duplication o f  the gene fo r  the peripheral myelin protein 22 observed an intense LNGF-R immunoreactivity in all layers
(PMP22) is the most common cause for Charcot-Marie- 
Tooth neuropathy type la  (CMT1A) neuropathy. In early
f e onion bulbs. In the most ad,vane 
se, characterized by massive onion
ges of tlu 
formation
stages o f the disease PMP22 is overexpressed in nerve no LNGF-R immunoreactivity was shown. In age-matched 
biopsies from. CMT1A patients. Recent studies with genetically control nerves LNGF-R staining was barely detectable, 
modified Schwann cells have demonstrated that the altered Furthermore, onion bulbs seen in patients with chronic
expression o f PMP22 modulates cell Thus we idiopathic polyneuropathy (CIDP) were always negative for
hypothesized that elevated expression o f PMP22 at the LNGF-R. In addition, at all CMT1A disease stages analysed,
beginning o f the disease might alter Schwann cell LNGF-R-positive Schwann cells were glial fibrillary acidic
differentiation and phenotype. In this study we investigated protein (GFAP) negative. Immunostaining with an antibody 
Schwann cell
ne ui using
'.rent stages of CMT1A to the proliferation marker, proliferating ce
markers. We found a 
nerve growth factor receptor (LNGF-R
expression
}
i ty
rred to in describe a disease stage-dependent altered *
nuclear
to established Schwann cell antigen (PCNA) indicated Schwann cell proliferation when
formation was well developed. In conclusion, we
the literature as p75) in numerous Schwann cells o f young phenotype in CMT1A neuropathy, which could 
CMT1A patients with almost normal myelin thickness and consequence of the PMP22 overexpression on
a ect
arm cell
very Jew onion bulbs. f 1* progression o f the ñour or, less likely, a secondan
disease, when Schwann cells began to form onion bulbs, we related to myelin loss.
Keywords: cell differentiation; CMT1A neuropathy; immunohistochemistry; low affinity NGF receptor; FMP22; Schwann
Abbreviations: CIDP = chronic inflammatory demyelinating polyneuropathy; CMT1A Marie-Tooth neuropathy
type la; GFAP = glial fibrillary acidic protein; LNGF-R = low affinity nerve growth factor receptor; MBP ® myelin basic 
protein; PCNA = proliferating cellular nuclear antigen; PMP22 = peripheral ->o
Introduction
Hereditary demyelinating neuropathies are a genetically 1996). Thus, duplication of the PMP22 gene is by far the
heterogeneous group of diseases, the majority of which are most common cause of CMT1 neuropathy.
caused either by duplication or deletion of the gene for Since there is strong evidence that the PMP22 gene is not
PMP22 or by point mutations in the genes PMP22, myelin disrupted within the tandem DNA duplication (Killian and 
protein P() or Connexin 32 (Patel and Lupski, 1994; Harding, Kloepfer, 1979; Chance et a l, 1992; Lupski et a l , 1992;
. According to two series, r v 70%
demyelinating hereditary neuropathies, named CMT1A, are
due to an ~l.5 megabase DNA tandem duplication
Matsunami et at., 1992; Patel et a i, 1992; Timmerman et al.,
«
*
has suggested.
mechanism 
\ analysis of PMP22 mRNA
containing the PMP22 gene (Fischbeck, 1993; Nelis et al., expression in sural nerves of CMT1A patients in several
© Oxford University Press 1996
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studies revealed that overexpression was found only in ~50% reasons and proved to have normal nerves during routine 
of the patients which seemed to be those in early stages of examination. Experiments have been approved by the local 
the disease (Hanemann et al., 1994, 1995; Yoshikawa et al.,
1994). Since the PMP22 gene is homologous to the gas3 
(growth arrest-specific) gene, a role for protein PMP22 in
ethical committee.
myelination and Schwann cell differentiation and growth has E p o n  s e c t io n s  a n d  m o r p h o m e tr y
been postulated and demonstrated in vitro (Spreyer et al., A whole sural nerve biopsy was performed and prepared
1991; Lemke, 1993; Zoidl et al., 1995). Based on this for light and electron microscopic examination, using 
findings, we hypothesized (Hanemann et al., 1994) that standard techniques (Gabreëls-Festen et al., 1992). Electron
elevated expression of PMP22 at the beginning of the disease microscopic photographs (X2200) covering ~10% of the
alters Schwann cell differentiation and leads to a pathological total transverse fascicular area were used for morphometric
phenotype. analysis. The density and diameter distribution of myelinated
Thus in this study, our investigations were designed to test fibres were determined using a Zeiss TGZ 3 particle size
whether the duplication of PMP22 in CMT1A patients is analyser. On the same prints, the external and axonal
associated with an alteration of the Schwann cell phenotype diameters were measured and the g ratio (axon diameter to
during the course of the disease as compared with normal fibre diameter) was determined. ‘Myelinated axons’ were
controls. those presumed to belong to the myelinated fibre group,
Various antibodies, such as those directed to the LNGF- namely axons with myelin and those of larger diameters
R, S I00 protein, GFAP and myelin proteins, have been used (>1.7 jam) without myelin but surrounded by one or more
in the past to characterize different Schwann cell phenotypes extra Schwann cell processes. The density of demyelinated
(Jessen and Mirsky, 1991; Fan and Gelman, 1992; Toews axons was determined and scored as percentage of the density
et al., 1992). Low affinity nerve growth factor receptor is of the myelinated fibres per case. The number of onion bulbs
expressed during proliferation of foetal Schwann cells but is was scored in randomly chosen areas comprising a total of
downregulated when myelination is initiated (at ~18 weeks myelinated
of foetal age) (Heumann et al., 1987; Yasuda et al., 1987; extra Schwann cell processes were considered ‘onion bulbs’ . 
DiStefano and Johnson, 1988; Scarpini et al., 1988). In 
normal human nerves LNGF-R is barely detectable (Sobue
et al., 1988), but it is re-expressed when axon-Schwann cell I m m u n o h is to c h e m is t r y
contact is lost during Wallerian degeneration or in acute but Nerves were fixed in 4% paraformaldehyde, embedded in
not chronic demyelination in rats and humans (Taniuchi et al.,
1986; Heumann et al., 1987; Fan and Gelman, 1992; Toews
paraffin and cut into 5-10 jim thick serial sections. For 
immunohistochemical staining the following primary
et al, 1992; Stoll et al., 1993). A similar regulation has been antibodies were used (dilution in parenthesis): mouse 
shown for GFAP expression in rats (Jessen et al., 1984, monoclonal anti-human LNGF-R (1:100); mouse monoclonal
1990; Toews et a l, 1992). anti-GFAP (1:10); mouse monoclonal anti-myelin
In this study we show expression of LNGF-R in Schwann protein (MBP) (1:500); mouse monoclonal PCNA (1:200)
cells of CMT1A nerve biopsies at early disease stages as (all Boehringer Mannheim, Penzberg, Germany); rabbit 
well as changes of LNGF-R staining during onion bulb monoclonal anti-S 100 (1:200; Camon, Wiesbaden, Germany), 
formation. These LNGF-R-positive Schwann cells were GFAP As secondary antibodies biotinylated anti-rabbit resp. rat 
negative indicating an unique Schwann cell phenotype in absorbed anti-mouse IgG (Vector, Burlingame, Calif., USA) 
CMT1A neuropathy that might result from the genetic defect. diluted 1:50 were used. Staining was performed with the
avidin-biotin-peroxidase complex method using Vectastain 
ABC kit (Vector) according to the manufacturer’s protocol.
/
Material and methods
N erve  sp ec im en s
of the sural nerve were taken from
Results
We have 13 CMT1A
patients diagnosed to suffer from CMT1A by clinical, biopsies. For 11 patients morphometric data are presented in
electrophysiological and pathological criteria according to Table 1. Morphometric results are ordered according to
the guidelines of the European consortium to study hereditary increase in percentage of onion bulbs and decrease in density
motor sensory neuropathy (De Visser et al., 1993) prior to of myelinated fibres. No such morphometric analysis was
the availability of genetic testing after informed consent. available for the two patients (Cases 12 and 13) with most
Years later diagnosis of CMT1A neuropathy was genetically 
proven by testing for PMP22 duplication as previously
advanced onion bulb formation, but routine histology on 
paraffin sections showed very large onion bulbs, and
described (Hoogendijk et al., 1992). Normal nerves were immunohistochemistry with MBP antibody revealed
taken either from multiorgan donors without neuropathy after severe loss of myelinated nerve fibres. Paraffin sections of 
informed consent or from patients biopsied for diagnostic sural nerve biopsies from patients in different age groups
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Table 1 Morphometrie ms of sural nerve biopsies from CMTIA patients
Case
1 2 3 4 5 6 7 8 9 10 11
Age (years) 4 4 5 6 17 15 21 13 15 22 26
TTFA % of normal for age 182 282 118 286 175 368 — 153 100 310 199
Density of MF (mm-2)* 7015 7030 9630 3900 1150 4430 1940 2200 2820 1040 2210
% of normal for age 50 50 68 30 11 42 20 21 15 11 23
% of demyelinated fibres 2.5 1.3 2.3 4.1 2.3 1.4 0.7 6.3 1.6 0 1 °
% of onion bulbs 27 35 37 72 78 83 94 96 100 100 100
Mean g ratio-1’ 0.59 0.56 0.5'5 0.62 0.52 0.50 0.53 0.61 0.62 0.58 0.42
# ratio % of normal for age 80 77 75 93 78 75 80 91 93 88 64
TTFA= total transverse fascicular area; MF »'im "“
years, n = 11); 10530 (11-20 years, n = 5); 9640 (21-30 years, n = 7). '''Mean of 
(6—10 years, n = 2), 0.67 (11-20 years, n ~ 3); 0.66 (21-50 years, n = 3).
an of age-related controls: 14170 (2-5 years, n — 6); 13180 (6-10
controls: 0.73 (2-5 years, n = 2); 0.67
(patient age at biopsy: 5 years, n = 2; 15 years, n = 2) showed with an antibody to GFAP showed no GFAP staining (Fig.
no abnormalities at routine morphological examination and 1H), which is in contrast to findings in acute demyelination,
endoneurial cells were only rarely LNGF-R or GFAP positive, where GFAP and LNGF-R are upregulated concomitantly
as previously described (Sobue et al., 1988) (results not 
shown).
(Toews et al., 1992).
When onion bulb formation and myelin fibre loss were
Immunostaining of sural nerves from patients with more advanced (Fig. 2A, E and G; Case 10 in Table I) LNGF-
genetically proven CMTIA neuropathy showed a massive R staining was increased and was clearly seen associated
increase in LNGF-R expression that varied depending on the with the onion bulbs (Fig. 2C); LNGF-R staining could be
stage of myelin loss and onion bulb formation, The early demonstrated in all lamellae of the onion bulbs including
stage of the disease was characterized by very few small 
onion bulbs (Ouvrier et al., 1987; Gabreëls-Festen et al.,
adjacent to sheaths (Fig. and E).
Incubation of these nerves with an against
1992), a moderate decrease in density of myelinated fibres and revealed a staining pattern very different to that of the LNGF- 
mostly normal myelin sheaths as revealed by morphometric R. Glial fibrillary acidic protein staining was increased as 
analysis (see Fig. IA and Case 1 in Table 1). In this group compared with controls but onion bulbs were GFAP negative
of patients, enhanced LNGF-R staining as compared with 
age-matched controls was observed (Fig. 1C and E). There associated with non-
s m Fig. 2G). The GFAP staining was presumably
were numerous LNGF-R-positive Schwann 
many normally myelinated nerve fibres 
Figure IB, D and F shows a more adv; 
showing an increased number of onion
mating Schwann cells (open arrows 
in Fig. 2G). At this more advanced disease stage, numerous 
1A and C). PCNA-positive nuclei were detectable, indicating Schwann
disease stage 
(Case 5,
cell
At most advanced stages ol , we
1). The crescent-shaped staining adjacent to no longer detect LNGF-R immunoreactivity (Fig. 2D) in
contour with LNGF-R antibody in transverse sections (Fig. accordance with a previous report (Sobue et al., . In
IE) and along nerve
longitudinal sections (Fig. ID and F) 
forming Schwann
that
in to nating
contrast to earlier disease stages, onion bulbs had 
larger in diameter (Fig. 2B) as revealed by labelling
aim mai •es still co nt
Schwann cells express LNGF-R (Fig. 1D-F). To analyse small MBP-positive myelin sheaths (arrows in Fig. 2F). 
whether the increased expression of LNGF-R in CMTIA onion of nerve
patients is related to enhanced Schwann cell proliferation, arrows in Fig. 2F). PCNA staining revealed no proliferating
sections were stained with monoclonal antibody to 
proliferation marker PCNA (Connolly et al., 1993).
was no
•  *
: staining at ear
cells at this late disease stage and staining with anti-GFAP was 
negative (data not shown). Despite the variable 
LNGF-R at different stages of onion bulb formation, Schwann
stages (data not shown). At slightly more advanced disease cells always remained SI 00 positive (Fig. 2B).
stages (Case 5, see Table 1, Fig. IB) only occasional single Staining of non-CMT onion bulbs in nerve bi
cells were PCNA positive (Fig. 1G). There was no PCNA CIDP patients showed no LNGF-R staining (Fig. 3D) as
immunoreaction in the endoneurium in any of the control perviously described (Sobue et al., 1988). Few onion bulbs
nerves from the different age groups examined. Further showed scarcely unmyelinated fibres in the outer layer as
characterization of Schwann cells at the early disease stages could be shown by ultrastructural analysis (Fig. 3A and B).
1464 C. 0. Hanemann et al.
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Discussion
In this study, we used different immunohistochemical markers 
to characterize Schwann cell phenotypes at various disease 
stages of CMTIA neuropathy as compared with age- 
matched normal controls. The principal finding of this study 
is that Schwann cells transiently and pathologically express 
LNGF-R in CMTIA neuropathy.
Schwann cells are the only endoneurial cells that are 
capable of expressing LNGF-R in peripheral nerves (Taniuchi
w reus in onion
were far too lew to explain staining of all lamellae in each 
onion bulb. Furthermore, morphometric analysis revealed 
evidence for demyelination in our series. In early disease
elination (Table I )
.it later disease stages, where LNGF-R staining could
in all layers of onionbe
Fig. 2E) virtually no signs of demyelination e
s (Case 10, Table I;
i no ear;'''" Ivdf *9 R
et al., 1986; Jessen and Mirsky, In normal adult expression and demyelinution« It has also n
human nerves we and others found virtually no endoneurial previously that LNGF-R is expressed in Schwann cells during
LNGF-R staining (Sobue et ah, In vitro non- •an i
*
in
m  an * * \ i  I prov
et a l 1990; Jessen and 
demyelination, LNGF-R
hypothesis that cell division is
signal for upregulation of LNGF-R expression (Toews et al.,
et ah , 
early stages
found LNGF-R
when no
demonstrated
myelinating Schwann cells normally express LNGF-R (Jessen
1991). In experimental 
occurs only at acute 
stages (Fan and Gelman, 1992; Stoll et al., 1993) and is 
downregulated early during remyelination. Accordingly, in 
nerve biopsies of chronic demyelinating diseases, like CIDP, 
with thinly myelinated nerve fibres and onion bulb formation 
LNGF-R staining could not be observed (Fig. 3D) (Sobue 
et al., 1988).
In this paper we show abnormal LNGF-R staining already 
present in numerous Schwann cells at very early stages 
of the hereditary demyelinating neuropathy, CMTIA. The 
crescent-shaped staining adjacent to the myelin sheath disease, when onion bulb 'formation is well underway, PC
the in
/  ♦
1
s, our
PCNA immune- 
to PCNA, an 
polymerase, gives an estimate of
et ah,and early S phase (Co
a
correlation between L
in CMTIA.
7-R expression and Sc
er, at later stages
suggests that myelin forming Schwann cells in CMTIA may 
also express LNGF-R in contrast to normal nerves where 
myelin forming Schwann cells are always LNGF-R negative. 
However, it is possible that a thin Schwann cell process is 
located next to the myelin sheath which does not express 
LNGF-R immunoreactivity. The biopsy material currently 
available for immunohistochemical studies does not allow a
answer to this question at
%
. In  i
i an i
anee w
mal expression of LNGF-R in
t ah.t
1988) LNGF-R was not found at the most advanced stages
of n massive onion bulb formation had
!» f1 fV%
11
to normal in late stages of CMTIA
At later stages of onion bulb formation we were able to show (Hanemann et ah, 1994} can only be speculated.
The finding of PCNA-positive Schwann cells, at advanced
for Schwann cell proliferation•■'ase stage, c
m to
that Schwann cells in all layers of the onion bulbs including 
those adjacent to the myelin sheath were LNGF-R positive.
Again this is unusual, since nerve biopsies of CIDP patients 
with a similar content of onion bulb formation and thinly demyelination is pronounced at the early stages, and onion 
myelinated nerve fibres were always LNGF-R negative (Fig. bulbs, as a result of Schwann cell proliferation, gradually 
3D) (Sobue et ah, 1988). Ultrastructural analysis showed appear later during the lirst decade of the disease (GabreiHs- 
few unmyelintated axons in the outer lamellae of some of Festen et al. i ). In addition, endoneurial
the onion bulbs (Fig. 3A and B). Since they were only found contribute to the pool of PCNA-positive proliferating cells, 
in few onion bulbs and were restricted to the outer lamellae, To further characterize the Schwann cells in CMTIA, we
14 66 C. 0. Hanemann et al.
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Low affinity NGFR expression in CMT1A nerve biopsies 1467
Fig, 3 Electronmierographs of onion bulbs in CMT1A (A and B; Case 9 in Table 1) and LNGF-R expression in CIDP (D). A shows
in the outer lamellae of an onion bulb, B shows an onion bulb where no axons can be seen in the outer 
lamellae,C shows a semi-thin section of a CIDP nerve and D shows negative staining for LNGF-R in CIDP. Magnifications: A, X4750;
* X5000: C. X600; I), >330,
of additional Schwann cell markers. from L
that GFAP is upregulated Fig. 2).
CMT1A neuropathy (see
together with LNGF-R if axon-Schwann cell contact is lost
demyel ¡nation, and Fan et al.< acute toxin
concomitantly
In conclusion, we describe an unique Schwann cell 
enotype in CMT1A neuropathy that has not been reported 
of S100 before. Early in the course of the disease with mostly normal
expression. We found SICK) labelling of all Schwann cells in myelin sheaths, Schwann cells express LNGF-R and S100
all t 'MTl A biopsies (data not shown). Glial fibrillary acidic but lack GFAP and PCNA staining. In more advanced disease
imnumostaining could only be detected in disease stages we found LNGF-R-positive, SI 00-positive and PCNA-
ongoing onion bulb formation and showed a positive Schwann cells in the inner as well as outer lamellae
pattern ol lo ca l iz a t io n  that is of the onion bulbs, which were still GFAP-negative.
> r  ^ ............. I M■ Mi 1 1 ~  -................
Fig. 2 Micrographs showing expression of LNGF-R and other markers at more advanced stages of CMT1A neuropathy. A shows that all 
myelinated fibres are surrounded by large onion bulbs of multiple Schwann cell lamellae (1 pm plastic section, Case 10 in Table 1). 
Some onion bulbs lack a central myelinated fibre (arrow). C, E, G and H are corresponding paraffin sections stained for LNGF-R 
{C and K}. GFAP (G> and PCNA (H). Note that Schwann cells in onion bulbs strongly express LNGF-R (arrows in C, and larger
. ________ \ ____ “U  * 1 ^  O  ¿"hi** t  v r a  v i n v n K  n  \ 7  QCCA/'iofA/l
express GFAP (arrows)l l H l g n U l U U H I U ,  rUJ. V* SH O W S H i m  O W U W m m  W U J  i n  u m u u  u u i l /o wv, nwv --------  v------ ----------------  - h r ’M'A
with nonmyelinated nerve fibres are GFAP positive (open arrows). In contrast to Fig. 1G, many nuclei are labelled by anti-PCNA
.. * * * i t* -.. i : ,. ..a t rxi' fK/A /IlcAficA inrli/^nl'incr ^ r h u /M n n  CCllS p r o l i f e r a t io n  (cltTOWS in  H ) .  B , D  cLIl(l v  3TCan it nod ics at urn mare aavancea stage ui me uiscrac jjjuiwauug ouiwiuju \------
immunusiained paraffin sections of a .sural nerve at most advanced CMTIA neuropathy. Note the well-developed onion bulbs as assessed 
hy staining of Schwann cells by S I00 antibodies (B) and the dramatic reduction of myelinated nerve fibres within these onion bulbs as 
shewn by MRP staining of remaining few myelin sheaths (arrows in F). Open arrows denote onion bulbs devoid of myelinated nerve 
fibre?». f'nnc(irmi»ntlv. LNGF-R immunoreactivity is lost at this most advanced stage of onion bulb formation (D). Magnifications:
~  *
libres. Concomitantly, LNGl 
A, X500; B. C. D and F-H, x 330; E, X825.
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The unusual LNGF-R expression by Schwann cells in 
CMT1A neuropathy could either be a primary effect due to 
PMP22 gene duplication and the growth regulatory functions
Fan X, Gelman BB. Schwann cell nerve growth factor receptor 
expression during initiation of remyelination. J Neurosci Res 1992; 
31: 58-67.
of PMP22 in the .cell cycle, or a secondary effect caused by Fischbeck KH. Charcot-Marie-Tooth disease type 1A, 9 November 
the disease process. It is an intriguing question whether or 1 9 9 2 , S a n  F r a n c i s c o ,  CA, USA. Neuromuscul Disord 1993;3:81-2.
not Schwann cells pathologically remain LNGF-R positive 
in foetal development after commencement of myelination 
in CMT1A neuropathy, an issue that obviously cannot be 
addressed experimentally. Nevertheless, the present findings 
support our earlier hypothesis that PMP22 gene duplication 
and overexpression may directly or secondarily alter the 
Schwann cell phenotype early in the course of the disease. 
At present, the functional consequences of aberrant LNGF- 
R expression of Schwann cells in CMT1A neuropathy is
AAWM
TW.
dominantly inherited demyelinating motor and sensory neuropathy 
(HMSN type 1). J Neurol Sci 1992; 107: 145-54.
W, van
Broeckhoven C, et al. Peripheral myelin protein-22 expression in 
Charcot-Marie-Tooth disease type IA sural nerve sies. J
Neurosci Res 1994: 37: 654-9.
unclear, since there are probably multiple roles of LNGF-R Hanemann CO, Stoll G, Müller I-IW. PMP22 expression in CMT1A 
in the peripheral nervous system. Taniuchi et al. (1988) put neuropathy [letter; comment]. Ann Neurol 1995; 37: 136. Comment
forward the hypothesis that Schwann cells present their 
surface LNGF-Rs, saturated with NGF, to ingrowing axons. 
Anton et al. (1994) provided evidence for a role of LNGF-R
in Schwann cell migration and Fan et al. (1992) hypothesized 809-18.
on: Ann Neurol 1994; 35: 445-50.
Harding AE. From the syndrome of Charcot, Marie and Tooth to 
disorders of peripheral myelin proteins. [Review]. Brain 1995; 118:
about a function for LNGF-R in the early phase of 
remyelination. Since both overexpression and point mutation 
of PMP22 lead to the same disease, future studies will have 
to be aimed to investigate whether point mutations of PMP22 
lead to the same abnormal Schwann cell differentiation state. 
In addition human Schwann cell cultures from CMT1A 
patients are needed for the functional characterization of 
these abnormal Schwann cells.
Heumann R, Lindholm D, Bandtlow C, Meyer M, Radeke MJ, 
Misko TP, et al. Differential regulation of mRNA encoding nerve 
growth factor and its receptor in rat sciatic nerve during development, 
degeneration, and regeneration: role of macrophages. Proc Natl
Acad Sci USA 1987; 84: 8735-9.
Hoogendijk JE, Hensels GW, Gabreels-Festen AAWM,
Janssen EA, de Jonghe P, et al. De-novo mutation in hereditary motor 
and sensory neuropathy type 1. Lancet 1992; 339: 1081-2.
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